Proinflammatory inflammasomes induce inflammation in the liver of patients with NAFLD, but an inflammasome-deficient model developed exacerbated hepatic steatosis and inflammation through the influx of TLR4 and TLR9 agonists into the portal vein [50]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.